Porphyria-Liver Problems Via Poison Dioxin.

This page: http://www.geocities.com/fltaxpayer/endocrine/13porphy.html

General Note: Dioxin causes expensive disabilities like porphyria and ADD/ADHD. Eliminate endocrine disruptors like dioxin and save $4,000/year/household on unnecessarily high Medicare and private medical insurance, disability taxes and extra income taxes to make up for taxes not paid by unnecessarily disabled people.

Ref. 14
Symptoms, Porphyria Endocrine Disruption

Many Pesticides and Chemical Warfare Agents are
designed to be porphyrinogenic.



We should not expose our children and adults to
porphyrinogenic substances like dioxin which cause
costly, disabling endocrine disrupting and gene damage.

Notice how many school and social behavioral bad
symptoms are in the following lists for untreated toxic
conditions associated with dioxin and related
chemicals.

============================
Dr.William Morton has estimated that better testing (and
probable continuing damage to the US gene pool like
related diabetes) has raised the porphyria rate
estimated from less than 1% to as much as 5%
[possibly 9%] of the population.

[rev.03/03/2000]

Redefinition of Abnormal Susceptibility to
Environmental Chemicals by Dr.William E.Morton.
This study looks at the porphyrin abnormalities in
MCS.
$4.40 Order No.
0112-MORT-95-018R

http://ciin.org/ Click on Library
[CIIN address changed, rev.03/03/2000]



Porphyria
==============================
[277.1] __ Disorders of porphyrin metabolism


Symptoms:

[277.1-1] __ Abdominal pain

[277.1-2] __ Abdominal tenderness

[277.1-3] __ Arosclerosis (sp) (scleradema [sp] of the
upper extremities, sometimes extending to the neck
and face)

[277.1-4] __ Alopecia (hair loss)

[277.1-5] __ Anemia; hypochromic, microcytic

[277.1-6] __ Amenorrhea (absence or suppression of
menstruation)

[277.1-7] __ Anemia, hemolytic

[277.1-8] __ Anxiety

[277.1-9] __ Aphonia (inability to produce sound)

[277.1-10] __ Appetite, loss of

[277.1-11] __ Back Pain

[277.1-12] __ Behavioral change

[277.1-13] __ Bladder distention

[277.1-14] __ Bowel incontinence

[277.1-15] __ Breast secretions

[277.1-16] __ Carbohydrate craving

[277.1-17] __ Cardiac arrest

[277.1-18] __ Central nervous system lesions

[277.1-19] __ Chest pain

[277.1-20] __ Coma

[277.1-21] __ Confusion

[277.1-22] __ Conjunctivitis

[277.1-23] __ Constipation

[277.1-24] __ Corneal inflammation

[277.1-25] __ Delirium

[277.1-26] __ Depression

[277.1-27] __ Diarrhea

[277.1-28] __ Disorientation

[277.1-29] __ Dysphasia (inability or difficulty
swallowing)

[277.1-30] __ Extremities become painful

[277.1-31] __ Facial hair, excessive

[277.1-32] __ Fatigue

[277.1-33] __ Fecal impaction

[277.1-34] __ Fever

[277.1-35] __ Foot drop

[277.1-36] __ Gag reflex, depressed

[277.1-37] __ Gastrointestinal spasms

[277.1-38] __ Hallucinations

[277.1-39] __ Hyperpigmentation

[277.1-40] __ Hypertension (high blood pressure)

[277.1-41] __ Hypoesthesia (sp) (dulled sensitivity to
touch)

[277.1-42] __ Hyponatraemia (sp) (decrease sodium in
blood)

[277.1-43] __ Hypotension, postural decrease in blood
pressure upon assuming an erect posture)

[277.1-44] __ Ileus (obstruction of the intestines)

[277.1-45] __ Insomnia

[277.1-46] __ Irritability

[277.1-47] __ Jaundice

[277.1-48] __ Joint pain or stiffness

[277.1-49] __ Limb stiffness

[277.1-50] __ Menstruation often exacerbates
symptoms

[277.1-51] __ Mood changes

[277.1-52] __ Muscle cramps

[277.1-53] __ Muscle pain or stiffness

[277.1-54] __ Nausea

[277.1-55] __ Nerve palsy; accessory, bulbar, facial,
hypoglossal, trigeminal loss of the ability to move or
control movement)

[277.1-56] __ Nightmares

[277.1-57] __ Organic brain syndrome

[277.1-58] __ Panic attacks

[277.1-59] __ Paralysis, partial

[277.1-60] __ Paralysis, temporary

[277.1-61] __ Paresthesia (numbness or tingling
sensation)

[277.1-62] __ Peripheral motor deficits

[277.1-63] __ Peripheral neuropathy

[277.1-64] __ Photosensitivity (porphyrins interacting
with sunlight causing neurologic and/or skin problems)

[277.1-65] __ Polyneuropathy

[277.1-66] __ Psychosis

[277.1-67] __ Restlessness

[277.1-68] __ Respiration, decreased

[277.1-69] __ Respiratory paralysis

[277.1-70] __ Retinal artery spasm

[277.1-71] __ Seizures (convulsions)

[277.1-72] __ Sensory disorders

[277.1-73] __ Skin lesions, blisters, or ulcers

[277.1-74] __ Sweating, profuse

[277.1-75] __ Tachycardia (heart rate of over 100
beats per minute)

[277.1-76] __ Tendon reflexes, absent or depressed

[277.1-77] __ Tremors

[277.1-78] __ Urinary incontinence

[277.1-79] __ Urine, changes in color of (usually red,
brown, or green)

[277.1-80] __ Urine retention

[277.1-81] __ Urine formation, absence of (Oliguria)

[277.1-82] __ Vision, changes in

[277.1-83] __ Voice, weakness

[277.1-84] __ Vomiting

[277.1-85] __ Weakness

[277.1-86] __ Wrist drop





The use of this survey is not a substitute for medical,
legal or other professional services.

Consult competent professionals for application,
confirmation of this information and for answers to
your specific questions.

Various other disclaimers and suggestions are present
in various toxicology reference books, etc.



Many porphyria patients develop sensitivity to
formaldehyde.
(This is by an indirect process by build up of endocrine
disrupting chemicals and gene damaging chemicals....via
porphyria system disruption resulting in suppression of the
P450 detox system).

Formaldehyde is found in schools, home, shopping
centers....

============================
Formaldehyde

(From "Chemical Exposure and Human Health",
Cynthia Wilson, McFarland & Co.

Jefferson NC and London, 800 253-2187.)

SYMPTOMS/DAMAGE:

Eye, ear and throat irritation;

Acidosis;

Acute sense of smell;

Altered tissue proteins;

Anemia;

Antibodies formation;

Apathy;

Blindness;

Blood in urine;

Blurred vision;

Body aches;

Bronchial spasms;

Bronchitis;

Burns, nasal and throat;

Cardiac impairment, palpations, and arrhythmias;

Central nervous system depression;

Changes in higher cognitive functions ;

Chemical sensitivity;

Chest pains and tightness;

Chronic vaginitis;

Colds;

Coma;

Conjunctivitis;

Constipation;

Convulsions;

Corneal erosion;

Cough;

Death;

Depression;

Dermatitis;

Diarrhea;

Difficulty Concentrating;

Disorientation;

Dizziness;

DNA damage;

Drowsiness;

Ear aches;

Eczema;

Emotional upsets;

Ethmoid polyps;

Fatigue;

Fecal Bleeding;

Fetal asphyxiation;

Flu-like or cold like illness;

Frequent urination with pain;

Gastritis;

Gastrointestinal inflammation;

Headaches;

Hemolytic anemia;

Hoarseness;

Hyperactive airway disease;

Hyperactivity;

Hypomenstrual syndrome;

Immune system sensitization;

Impaired attention span;

Impaired capacity to focus attention;

Inability or difficulty swallowing;

Inability to recall words and names;

Inconsistent IQ profiles;

Inflammatory diseases of the reproductive organs;

Intestinal pain;

Intrinsic asthma;

Irritability;

Jaundice;

Joint pain, aches and swelling;

Kidney pain;

Laryngeal spasm;

Loss of memory;

Loss of sense of smell;

Loss of taste;

Malaise;

Menstrual and testicular pain;

Menstrual irregularities;

Metallic taste;

Muscle spasms and cramps;

Nasal congestion, Crusting and mucosa inflammation;

Nausea;

Nosebleeds;

Numbness and tingling of the forearms and finger tips;

Pale, clammy skin;

Partial laryngeal paralysis;

Pneumonia;

Post nasal drip;

Pulmonary edema;

Reduced body temperature;

Retarded speech pattern;

Ringing or tingling in the ear;

Schizophrenic-type symptoms;

Sensitivity to sound;

Shock;

Short term memory loss;

Shortness of breath;

Skin lesions;

Sneezing;

Sore throat;

Spacey feeling;

Speaking difficulty;

Sterility;

Swollen glands;

Tearing;

Thirst;

Tracheitis:

Tracheobronchitis;

Vertigo;

Vomiting blood;

Vomiting;

Wheezing;

Suspected of causing cancer (see comment from

NIOSH).

Genetic mutations;

Chromosomal damage;



Metabolized as formic acid.

Note: Will cross sensitize to formic acid.

Comparison of ciliostatic effects showed
formaldehyde to the most toxic of the aldehydes.

EPA estimates that 15 people in 1 million will get
cancer from lifetime exposure of 1 ppb.

Neurotoxin.

Trade Names/synonyms: Quaternium-15; Metanal;
Meltyl aldehyde; Methylene oxide; Formalin; Formic
aldehyde; Formalith; Fyde; BVF; Morbicid;
Oxymethylene; Oxomethane; Lysoform;
Superlysoform; Fannoform; Ivalon.

NIOSH: Carcinogen at any exposure level;

NIOSH REL: 0.016 ppm (10 hr/day 40 hr.
wk); 0.100 ppm (ceiling limit to not exceed 15
minutes);

OSHA: PEL: 0.750 ppm (8 hr/day-40 hr/wk-PP/S);

2000 ppm (exposure to not exceed 15 min);

NAS: There is no (constant) population threshold for
irritation effects;

NRC: Fewer than 20% but perhaps no more 10% of
the general population may be suspectable to
formaldehyde and may react acutely at any exposure
level;

ACGIH: Suspected human carcinogen;

IDLH: 30 ppm;

CEHH Page 182;

References: 84,17,18,30,31,129,278,279,285,
88,290,297,299,300,304,305,309,
388,389,394,416,417a,421,423,426,457.

8. Berthold-Bond, A., Clean & Green, Woodstock, NY:
Cress Press, 1990.

14. Chesebrough-Ponds USA Co., product label for Rave
All in One hair spray 1992.

17. Concrete Facts, "99.99 Percent?" March 1991, Vol.1
no.1 and/or Rachel's Hazardous Waste News #207,
"Hardardous Waste Incineration- Part 4; Real
Alternatives to Incinerations," November 14, 1988.

18. "Congress: HR 1066 Needed to Turn Heat Up on
Employers, Regulators, Congress Told", Indoor Air
Pollution News, Washington, DC: Buraff, August 22,
1991.

30. Lander Co., product label for Rose Scented Skin
Cream, ca. 1992.

31. Lander Co., product label for Vitamin E Lotion, ca.
1992.

129. "National Library of Medicine's Toxicology
Information Program, Agency for Toxic Substances
and Disease Registry, Hazardous Substances Data
Bank, "Formaldehyde", as of January 11, 1992.

279. National Research Council, Assembly of Life
Sciences, Committee on Aldehydes, Based on
Toxicology and Environmental Health Hazards,
Formaldehydes and other Aldehydes, Washington, DC:
National Academy Press, 1981.

285. New Jersey Department of Health, "Hazardous
Substance Fact Sheet "Formaldehyde", 1986.

288. Proctor and Gamble Co., label for Ivory Free
Conditioner, U.S. patent pending.

290. Redmond Products, product label for Aussie Mega
Shampoo with Papaya, 1986.

297. Swanson, J.R., "Formaldehyde: The Psychological and
Educational Implications of Formaldehyde
Toxicology," Seattle, WA: University of Washington,
College of Education, 1984.

299. Thomas, C.L., editor, Taber's Cyclopedic Medical
Dictionary, 16 th edition Philadelphia, PA: F.A.
Davis Company, 1989.



==========================
GCJeffrey Macro view from combining papers from
various researchers.



Primary Endocrine Disrupters

e.g. Dioxin, etc. at very low levels <-----*1
|
V
Porphyria and related Detox System Disruption/Overloads
|
V
Build up of "Secondary Toxins" <--*2
(e.g. formaldehyde) and more "Primary Toxins"
|
V
More Permanent Gene Damage---->*2---- >*1


*1 and *2 "Repeat of above because of Avalanche"



Chronic Degenerative Diseases "Cognitive Deficits"
"Behavioral Problems"
"Diabetes"
"Porphyria"
"Cancer"
"Neurological Effects" (e.g. ALS symptoms)


For chemicals which cause porphyria and the
other listed diseases above, see three of Cynthia
Wilson's publications:

1. 3,700 "Porphyrinogenic Substances"
http://www.ciin.org/
Click on Library
Scroll down to porphyria
(Rev. 6/25/2000)

2. "Chemical Exposure and Human Health"
http://www.ciin.org/
Click on Book
(Rev. 6/25/2000)

Monthly "Our Toxic Times"
http://www.ciin.org/
Click on Library
(Rev. 6/25/2000)



ED Briefing Book Main Pages:
| Endocrine Disruption Briefing Book | | Attachment List, ED Briefing Book |

Attachment Pages:
| ADD/ADHD | | Children-Developmental Damage | | Symptoms, Physical-Cognitive | | Diabetes | | Porphyria-LiverSpots | | Porphyria-Suppressed Detox | | Thyroid Disruptions | | Cancer, et al | | Cancer, et al |

| Bethune School Dioxin | | Whitehouse School Scandal | | Belgium Govt. Topples | | 314 Toxic Chemicals | | 3700 Porphyrinogenic Chemicals | | Professional Dioxin Reports | | Industry View Dioxin | | Dust Carries Toxics (Dioxin) |

Cost Estimates, For Medical & Social Problems: |
Overview 5 most costly dioxin diseases |

ED Briefing Book Main Pages:
| Endocrine Disruption Briefing Book | | Attachment List, ED Briefing Book |

Attachment Pages:
| ADD/ADHD | | Children-Developmental Damage | | Symptoms, Physical-Cognitive | | Diabetes | | Porphyria-LiverSpots | | Porphyria-Suppressed Detox | | Thyroid Disruptions | | Cancer, et al | | Cancer, et al |

| Bethune School Dioxin | | Whitehouse School Scandal | | Belgium Govt. Topples | | 314 Toxic Chemicals | | 3700 Porphyrinogenic Chemicals | | Professional Dioxin Reports | | Industry View Dioxin | | Dust Carries Toxics (Dioxin) |

Cost Estimates, For Medical & Social Problems: |
Overview 5 most costly dioxin diseases |

Additional Overview Info:
| PCB Toxicity by CDC | | 48% Graduation Rate Jax FL | | EDSTAC |
| EPA Dioxin Report Chap 9, Health Effects | | EPA 1994 Dioxin Report, other chapters | | Court Affidavit of Dioxin Damage | | Solutions to Dioxin Problem |


Send questions to:
| [email protected] | | [email protected] |

The National Issues Site:....United We Stand America www.uwsa.com


Terms of Use

Hosted by www.Geocities.ws

1